Annexin Pharmaceuticals AB (publ) (STO: ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.530
-0.024 (-4.33%)
Sep 2, 2024, 11:26 AM CET

ANNX Revenue

Annexin Pharmaceuticals AB had revenue of 16.16M SEK in the quarter ending June 30, 2024, with 20.43% growth. This brings the company's revenue in the last twelve months to 62.59M, up 26.77% year-over-year. In the year 2023, Annexin Pharmaceuticals AB had annual revenue of 56.35M with 26.38% growth.

Revenue (ttm)
62.59M
Revenue Growth
+26.77%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
295.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202356.35M11.76M26.38%
Dec 31, 202244.59M10.99M32.69%
Dec 31, 202133.60M7.30M27.73%
Dec 31, 202026.31M437.00K1.69%
Dec 31, 201925.87M3.72M16.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca PLC 520.76B
ABB Ltd 342.58B
Investor AB (publ) 240.73B
Investor AB (publ) 240.73B
Atlas Copco AB 177.12B
Atlas Copco AB 177.12B
AB Volvo (publ) 552.20B
AB Volvo (publ) 552.20B
Revenue Rankings